Research Square

Combined GLP-1 Receptor Agonist and SGLT2 Inhibitor Therapy for Adults with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease: A Large-Scale Target Trial Emulation

By Hsueh-Fen Bai, Ming-Hsien Tsai, Yu-Wei Fang, Pei-Sung Hsu

Preprint: cohort study of 17,467 peopleInterventions

The paper

Hsueh-Fen Bai, Ming-Hsien Tsai, Yu-Wei Fang, Pei-Sung Hsu

Shin Kong WHS Memorial Hospital

Research Square, 31 Aug 2026, Preprint, not peer-reviewed

doi.org/10.21203/rs.3.rs-10427939/v1

Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression